1. Glyn-Jones, S. et al. Osteoarthritis. Lancet 386, 376–387. https://doi.org/10.1016/S0140-6736(14)60802-3 (2015).
2. Thomas, A. C., Hubbard-Turner, T., Wikstrom, E. A. & Palmieri-Smith, R. M. Epidemiology of posttraumatic osteoarthritis. J. Athl. Train 52, 491–496. https://doi.org/10.4085/1062-6050-51.5.08 (2017).
3. Gelber, A. C. et al. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann. Intern. Med. 133, 321–328. https://doi.org/10.7326/0003-4819-133-5-200009050-00007 (2000).
4. McKinley, T. O., Borrelli, J., D’Lima, D. D., Furman, B. D. & Giannoudis, P. V. Basic science of intra-articular fractures and post- traumatic osteoarthritis. J. Orthop. Trauma 24, 567–570. https://doi.org/10.1097/BOT.0b013e3181ed298d (2010).
5. Cinque, M. E., Dornan, G. J., Chahla, J., Moatshe, G. & LaPrade, R. F. High rates of osteoarthritis develop after anterior cruciate ligament surgery: an analysis of 4108 patients. Am. J. Sports Med. 46, 2011–2019. https://doi.org/10.1177/0363546517730072 (2018).
6. Marsh, J. L. et al. Articular fractures: does an anatomic reduction really change the result?. J. Bone Joint Surg. Am. 84, 1259–1271 (2002).
7. Anderson, D. D. et al. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J. Orthop. Res. 29, 802–809. https://doi.org/10.1002/jor.21359 (2011).
8. Lewis, J. S. et al. Genetic and cellular evidence of decreased inflammation associated with reduced incidence of posttraumatic arthritis in MRL/MpJ mice. Arthritis Rheum. 65, 660–670. https://doi.org/10.1002/art.37796 (2013).
9. Punzi, L. et al. Post-traumatic arthritis: overview on pathogenic mechanisms and role of inflammation. RMD Open 2, e000279. https://doi.org/10.1136/rmdopen-2016-000279 (2016).
10. Tchetverikov, I. et al. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann. Rheum. Dis. 64, 694–698. https://doi.org/10.1136/ard.2004.022434 (2005).
11. Coleman, M. C. et al. Targeting mitochondrial responses to intra-articular fracture to prevent posttraumatic osteoarthritis. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aan5372 (2018).
12. Riegger, J. & Brenner, R. E. Pathomechanisms of posttraumatic osteoarthritis: chondrocyte behavior and fate in a precarious environment. Int. J. Mol. Sci. https://doi.org/10.3390/ijms21051560 (2020).
13. Meyer, H. & Weihl, C. C. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J. Cell Sci. 127, 3877–3883. https://doi.org/10.1242/jcs.093831 (2014).
14. Koike, M. et al. Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression. J. Biol. Chem. 285, 21736–21749. https://doi.org/10.1074/jbc.M109.099283 (2010).
15. Ikeda, H. O. et al. Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa. Sci. Rep. 4, 5970. https://doi.org/10.1038/srep05970 (2014).
16. Ide, Y. et al. Cardioprotective effects of VCP modulator KUS121 in murine and porcine models of myocardial infarction. JACC Basic Transl. Sci. 4, 701–714. https://doi.org/10.1016/j.jacbts.2019.06.001 (2019).
17. Hasegawa, T. et al. Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration. Sci. Rep. 6, 31184. https://doi.org/10.1038/srep31184 (2016).
18. Muraoka, Y. et al. KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degen- eration. Heliyon 4, e00624. https://doi.org/10.1016/j.heliyon.2018.e00624 (2018).
19. Nakano, N. et al. Neuroprotective effects of VCP modulators in mouse models of glaucoma. Heliyon 2, e00096. https://doi. org/10.1016/j.heliyon.2016.e00096 (2016).
20. Kinoshita, H. et al. KUS121, a valosin-containing protein modulator, attenuates ischemic stroke via preventing ATP depletion. Sci. Rep. 9, 11519. https://doi.org/10.1038/s41598-019-47993-w (2019).
21. Hata, M. et al. KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress. Sci. Rep. 7, 44873. https://doi.org/10.1038/srep44873 (2017).
22. Nakano, M. et al. ATP maintenance via two types of ATP regulators mitigates pathological phenotypes in mouse models of Par- kinson’s disease. EBioMedicine 22, 225–241. https://doi.org/10.1016/j.ebiom.2017.07.024 (2017).
23. Ikeda, H. O. et al. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: an open-label, non-randomized, first-in-humans, phase 1/2 trial. PLoS ONE 15, e0229068. https://doi.org/10.1371/ journal.pone.0229068 (2020).
24. Takada, K. et al. Enhanced apoptotic and reduced protective response in chondrocytes following endoplasmic reticulum stress in osteoarthritic cartilage. Int. J. Exp. Pathol. 92, 232–242. https://doi.org/10.1111/j.1365-2613.2010.00758.x (2011).
25. Uehara, Y. et al. Endoplasmic reticulum stress-induced apoptosis contributes to articular cartilage degeneration via C/EBP homolo- gous protein. Osteoarthritis Cartil. 22, 1007–1017. https://doi.org/10.1016/j.joca.2014.04.025 (2014).
26. Guo, F. J. et al. ATF6 upregulates XBP1S and inhibits ER stress-mediated apoptosis in osteoarthritis cartilage. Cell Signal 26, 332–342. https://doi.org/10.1016/j.cellsig.2013.11.018 (2014).
27. Husa, M., Petursson, F., Lotz, M., Terkeltaub, R. & Liu-Bryan, R. C/EBP homologous protein drives pro-catabolic responses in chondrocytes. Arthritis Res. Ther. 15, R218. https://doi.org/10.1186/ar4415 (2013).
28. Chen, J. et al. Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. Cell Death Dis. 9, 212. https://doi.org/10.1038/ s41419-017-0217-y (2018).
29. Schenker, M. L., Mauck, R. L., Ahn, J. & Mehta, S. Pathogenesis and prevention of posttraumatic osteoarthritis after intra-articular fracture. J. Am. Acad. Orthop. Surg. 22, 20–28. https://doi.org/10.5435/JAAOS-22-01-20 (2014).
30. Lieberthal, J., Sambamurthy, N. & Scanzello, C. R. Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartil. 23, 1825–1834. https://doi.org/10.1016/j.joca.2015.08.015 (2015).
31. Qiu, Q. et al. Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis. EMBO J. 32, 2477– 2490. https://doi.org/10.1038/emboj.2013.183 (2013).
32. Tsuru, A., Imai, Y., Saito, M. & Kohno, K. Novel mechanism of enhancing IRE1α-XBP1 signalling via the PERK-ATF4 pathway. Sci. Rep. 6, 24217. https://doi.org/10.1038/srep24217 (2016).
33. Ji, X. et al. Effects of in vivo cyclic compressive loading on the distribution of local Col2 and superficial lubricin in rat knee cartilage. J. Orthop. Res. https://doi.org/10.1002/jor.24812 (2020).
34. Mankin, H. J., Dorfman, H., Lippiello, L. & Zarins, A. Biochemical and metabolic abnormalities in articular cartilage from osteo- arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg. Am. 53, 523–537 (1971).
35. Ostergaard, K., Petersen, J., Andersen, C. B., Bendtzen, K. & Salter, D. M. Histologic/histochemical grading system for osteoarthritic articular cartilage: reproducibility and validity. Arthritis Rheum. 40, 1766–1771. https://doi.org/10.1002/art.1780401007 (1997).
36. Gupta, P. K. et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res. Ther. 18, 301. https://doi.org/10.1186/ s13075-016-1195-7 (2016).
37. Jackson, M. T. et al. Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms. Arthritis Rheumatol. 66, 3337–3348. https://doi.org/10.1002/ art.38876 (2014).
38. Nishitani, K. et al. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes. J. Cell Biochem. 109, 425–433. https://doi.org/10.1002/jcb.22421 (2010).